Evidence map›Paper›PMID 8631305›Full record

ArticleThe EMBO journal1996

B-type cyclins regulate G1 progression in fission yeast in opposition to the p25rum1 cdk inhibitor.

C Martin-Castellanos, K Labib, S Moreno

Abstract read
In one paragraph

Article in The EMBO journal, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Review
  2. Cyclin-dependent kinases: Masters of the eukaryotic universe.Wiley interdisciplinary reviews. RNA · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Requirement of PP2A-B56iScience · 2020
    Article
  7. Article
  8. Protein Phosphatases in G1 Regulation.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Cell cycle control by a minimal Cdk network.PLoS computational biology · 2015
    Article
  11. Pom1 and cell size homeostasis in fission yeast.Cell cycle (Georgetown, Tex.) · 2013
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C Martin-CastellanosInstituto de Microbiologia-Bioquimica, CSIC/Universidat de Salamanca, Spain.
K Labib
S Moreno

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The onset of S phase in fission yeast is regulated at Start, the point of commitment to the mitotic cell cycle. The p34cdc2 kinase is essential for G1 progression past Start, but until now its regulation has been poorly understood. Here we show that the cig2/cyc17 B-type cyclin has an important role in G1 progression, and demonstrate that p34cdc2 kinase activity is periodically associated with cig2 in G1. Cells lacking cig2 are defective in G1 progression, and this is particularly clear in small cells that must regulate Start with respect to cell size. We also find that the cig1 B-type cyclin can promote G1 progression. Whilst p25rum1 can inhibit cig2/cdc2 activity in vitro, and may transiently inhibit this complex in vivo, cig1 is regulated independently of p25rum1. Since cig1/cdc2 kinase activity peaks in mitotic cells, and decreases after mitosis with similar kinetics to cdc13-associated kinase activity, we suggest that cig2 is likely to be the principal fission yeast G1 cyclin. cig2 protein levels accumulate in G1 cells, and we propose that p25rum1 may transiently inhibit cig2-associated p34cdc2 activity until the critical cell size required for Start is reached.

Indexed as

Cell CycleCell Cycle ProteinsMitosisSchizosaccharomyces pombe ProteinsCDC2 Protein KinaseCyclin BCyclinsEnzyme InhibitorsFungal ProteinsGenes, FungalSchizosaccharomycesCDC2 Protein KinaseCell Cycle ProteinsCig2 protein, S pombeCyclin BCyclinsEnzyme InhibitorsFungal Proteinspuc1 protein, S pombeRum1 protein, S pombeSchizosaccharomyces pombe Proteins

Identifiers

PMID8631305
PMCPMC450282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.